#IMPAACT4TB

3HP dispersible child-friendly formulation in Ethiopia, promising results | KNCV Tuberculosis August 2025 marked the closure of the Pediatric Demonstration Study (PDS) in Ethiopia, part of the Unitaid-funded IMPAACT4TB project. The Closeout Workshop, hosted by KNCV TB Plus at Yatu Hotel in Bis...

3HP dispersible child-friendly formulation in Ethiopia, promising results🔥
Pediatric Demonstration Study (PDS) in #Ethiopia
🔥15 health facilities engaged
🔥205 children enrolled in #TB preventive treatment (TPT), of which 163 on the new dispersible #3HP.👏

#TBSky #IMPAACT4TB @unitaid.bsky.social

IMPAACT4TB's Paediatric Demonstration Study in Ethiopia The Paediatric Demonstration Study (PDS) training and orientation was held in Ethiopia on Feb 6. PDS is part of the IMPAACT4TB studies.

The #IMPAACT4TB Paediatric Demonstration Study (PDS) is making a real difference by generating evidence on the child-friendly, dispersible #TB preventive treatment.🛡

But innovation and evidence alone aren’t enough, involving interest-holders is key! 🔑

Together we can end TB!🤝 #IDSky #TBSky

KNCV Tuberculosis Foundation 📢 Great news from Yayasan KNCV Indonesia! 🎉 📆 On 15th of January, Indonesia reached 💯% of the enrollment target for the 1-to-3 study part of the #IMPAACT4TB project. In #Indonesia, the 1-to-3...

📢 Great news from Yayasan KNCV Indonesia! 🎉

📆 Indonesia reached 💯% of the enrollment target for the 1-to-3 study part of the #IMPAACT4TB project.👏 Just last week (31 of January), the study site in #Indonesia stopped enrollment after reaching the target 2 weeks earlier.
#IDSky #TPT
Learn more here👇